Elite Health Systems Inc.
جودة البيانات: 100%
EHSI
OTC
Services
Health Services
KWD 1.25
▼
KWD 0.01
(-0.79%)
القيمة السوقية: 27.64 M
السعر
KWD 1.26
القيمة السوقية
27.64 M
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—
Quick Summary
النقاط الرئيسية
Negative free cash flow of -1.98 M
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-69.19%
أقل من متوسط القطاع (-15.95%)
ROIC-45.13%
Net MarginN/A
Op. MarginN/A
الأمان
Debt / Equity
N/A
Current Ratio15.83
Interest CoverageN/A
التقييم
PE (TTM)
-9.07
أقل من متوسط القطاع (-1.17)
P/B Ratio5.51
EV/EBITDAN/A
Dividend YieldN/A
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Services (502 نظير)
مقارنة الأقران
مقابل وسيط قطاع Services (502 نظير)| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -9.1 | -1.2 |
| P/B | 5.5 | 1.4 |
| ROE % | -69.2 | -16.0 |
| Net Margin % | — | -19.4 |
| Rev Growth 5Y % | — | 3.8 |
| D/E | — | 0.4 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -3.05 M |
| ROE | -69.19% | ROA | -65.56% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -1.98 M |
| ROIC | -45.13% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 15.83 |
| Interest Coverage | N/A | Asset Turnover | 0.00 |
| Working Capital | 4.00 M | Tangible Book Value | 5.02 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -9.07 | Forward P/E | N/A |
| P/B Ratio | 5.51 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -7.14% | ||
| Market Cap | 27.64 M | Enterprise Value | 23.67 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | 0.00 |
| FCF / Share | -0.09 | OCF / Share | -0.09 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 64.82% |
| SBC-Adj. FCF | -2.48 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 1.06 M | 3.17 M |
| Net Income | -2.06 M | -816,000.0 | -1.34 M | -627,000.0 | 533,000.0 |
| EPS (Diluted) | — | -0.17 | -0.17 | -0.08 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -1.79 M | -765,000.0 | -1.39 M | -89,000.0 | 1.62 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | 1.79 M | 765,000.0 | 1.39 M | 1.06 M | 1.20 M |
| D&A | — | — | — | — | — |
| Interest Expense | — | 2,000.0 | 0.0 | 3,000.0 | 25,000.0 |
| Income Tax | -163,000.0 | 0.0 | 39,000.0 | 120,000.0 | 323,000.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 4.32 M | 1.32 M | 1.75 M | 3.69 M | 4.17 M |
| Total Liabilities | 143,000.0 | 676,000.0 | 291,000.0 | 361,000.0 | 487,000.0 |
| Shareholders' Equity | 4.18 M | 645,000.0 | 1.24 M | 2.83 M | 3.69 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 4.03 M | 466,000.0 | 1.54 M | 2.18 M | 2.03 M |
| Current Assets | 4.25 M | 527,000.0 | 1.56 M | 2.24 M | 3.01 M |
| Current Liabilities | 94,000.0 | 607,000.0 | 280,000.0 | 327,000.0 | 410,000.0 |
{"event":"ticker_viewed","properties":{"ticker":"EHSI","listing_kind":"stock","pathname":"/stocks/ehsi","exchange":"OTC","country":"US"}}